Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

4.030

+0.035 (0.88%)

At close: Feb 6, 2026, 4:00 PM EST

3.945

-0.085 (-2.11%)

After-hours: Feb 6, 2026, 5:05 PM EST

Neuphoria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	22	13	-	-	-	-
Enterprise Value	8	-4	-	-	-	-
Last Close Price	4.01	7.10	-	-	-	-
PS Ratio	0.48	0.85	-	-	-	-
PB Ratio	0.76	0.70	-	-	-	-
P/TBV Ratio	-	2.40	-	-	-	-
P/FCF Ratio	30.13	172.83	-	-	-	-
P/OCF Ratio	30.13	172.83	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.01	0.02
Debt / FCF Ratio	0.17	1.93	-	-	-	-
Asset Turnover	0.62	0.56	-	-	0.10	0.02
Quick Ratio	2.66	3.37	3.33	4.58	12.02	12.55
Current Ratio	2.72	3.56	3.45	4.87	12.46	13.10
Return on Equity (ROE)	-64.04%	-2.03%	-78.44%	-71.40%	-41.64%	-28.86%
Return on Assets (ROA)	-7.25%	-1.84%	-39.58%	-37.41%	-18.40%	-14.48%
Return on Capital Employed (ROCE)	-13.10%	-3.40%	-74.70%	-83.50%	-28.40%	-19.80%
Earnings Yield	-43.92%	-2.77%	-	-	-	-
FCF Yield	3.32%	0.58%	-	-	-	-
Buyback Yield / Dilution	99.94%	-95.01%	99.94%	-8.53%	-73.52%	-43.14%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q